Stocks and Investing
Stocks and Investing
Thu, July 11, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Raghuram Selvaraju Maintained (ANVS) at Strong Buy with Increased Target to $30 on, Jul 11th, 2024
Raghuram Selvaraju of HC Wainwright & Co., Maintained "Annovis Bio, Inc." (ANVS) at Strong Buy with Increased Target from $23 to $30 on, Jul 11th, 2024.
Raghuram has made no other calls on ANVS in the last 4 months.
There are 2 other peers that have a rating on ANVS. Out of the 2 peers that are also analyzing ANVS, 0 agree with Raghuram's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Raghuram
- Elemer Piros of "Rodman & Renshaw" Reiterated at Strong Buy and Held Target at $67 on, Tuesday, July 2nd, 2024
- Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $26 on, Tuesday, April 30th, 2024
Contributing Sources